de Graaf SS - Search Results

1

Vincristine pharmacokinetics after repetitive dosing in children.

Gidding CE, Meeuwsen-de Boer GJ, Koopmans P, Uges DR, Kamps WA, de Graaf SS. Gidding CE, et al. Among authors: de graaf ss. Cancer Chemother Pharmacol. 1999;44(3):203-9. doi: 10.1007/s002800050968. Cancer Chemother Pharmacol. 1999. PMID: 10453721 Clinical Trial.

2

Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.

Plasschaert SL, Groninger E, Boezen M, Kema I, de Vries EG, Uges D, Veerman AJ, Kamps WA, Vellenga E, de Graaf SS, de Bont ES. Plasschaert SL, et al. Among authors: de vries eg, de bont es, de graaf ss. Clin Pharmacol Ther. 2004 Sep;76(3):220-9. doi: 10.1016/j.clpt.2004.05.007. Clin Pharmacol Ther. 2004. PMID: 15371983

3

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.

Frost BM, Lönnerholm G, Koopmans P, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Uges DR, de Graaf SS. Frost BM, et al. Among authors: de graaf ss. Acta Paediatr. 2003 May;92(5):551-7. Acta Paediatr. 2003. PMID: 12839283 Clinical Trial.

4

Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species?

Groninger E, Meeuwsen-De Boer GJ, De Graaf SS, Kamps WA, De Bont ES. Groninger E, et al. Among authors: de bont es, de graaf ss. Int J Oncol. 2002 Dec;21(6):1339-45. doi: 10.3892/ijo.21.6.1339. Int J Oncol. 2002. PMID: 12429986

5

Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.

Groninger E, Meeuwsen-de Boar T, Koopmans P, Uges D, Sluiter W, Veerman A, Kamps W, de Graaf S. Groninger E, et al. Pediatr Res. 2002 Jul;52(1):113-8. doi: 10.1203/00006450-200207000-00021. Pediatr Res. 2002. PMID: 12084857 Clinical Trial.

6

An automated HPLC method to determine intracellular vincristine concentrations in mononuclear cells of children with acute lymphoblastic leukemia.

Groninger E, Koopmans P, Kamps W, de Graaf S, Uges D. Groninger E, et al. Ther Drug Monit. 2003 Aug;25(4):441-6. doi: 10.1097/00007691-200308000-00004. Ther Drug Monit. 2003. PMID: 12883226

7

Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).

Groninger E, Meeuwsen-de Boer T, Koopmans P, Uges D, Sluiter W, Veerman A, Kamps W, de Graaf S. Groninger E, et al. Eur J Cancer. 2005 Jan;41(1):98-103. doi: 10.1016/j.ejca.2004.10.006. Eur J Cancer. 2005. PMID: 15617994

8

Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration.

Kellie SJ, Barbaric D, Koopmans P, Earl J, Carr DJ, de Graaf SS. Kellie SJ, et al. Among authors: de graaf ss. Cancer. 2002 Mar 15;94(6):1815-20. doi: 10.1002/cncr.10397. Cancer. 2002. PMID: 11920545 Free article. Clinical Trial.

9

Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.

Kellie SJ, Koopmans P, Earl J, Nath C, Roebuck D, Uges DR, De Graaf SS. Kellie SJ, et al. Among authors: de graaf ss. Cancer. 2004 Jun 15;100(12):2637-43. doi: 10.1002/cncr.20220. Cancer. 2004. PMID: 15197807 Free article. Clinical Trial.

10

Vincristine disposition in children with acute lymphoblastic leukemia.

de Graaf SS, Bloemhof H, Vendrig DE, Uges DR. de Graaf SS, et al. Med Pediatr Oncol. 1995 Apr;24(4):235-40. doi: 10.1002/mpo.2950240405. Med Pediatr Oncol. 1995. PMID: 7700168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters